The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine safety and efficacy for the next respiratory viral season, an apparent tacit rebuke of the federal government’s current regulations. The AMA’s evaluation process will be conducted in collaboration with the Vaccine Integrity Project at the Center for…
Analysis & Context
The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine safety and efficacy for the next respiratory viral season, an apparent tacit rebuke of the federal government’s current regulations. The AMA’s evaluation process will be conducted in collaboration with the Vaccine Integrity Project at the Center for… This article provides comprehensive coverage and analysis of current events.
The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine safety and efficacy for the next respiratory viral season, an apparent tacit rebuke of the federal government’s current regulations. The AMA’s evaluation process will be conducted in collaboration with the Vaccine Integrity Project at the Center for…
